To the Editor: The article by Mant et al1 and the letters following its publication focus attention on a long-standing problem that, despite concerted efforts by governments, healthcare providers and other stakeholders to address it, remains a major obstacle to effective and appropriate continuity of pharmacotherapy following discharge from hospital.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
Correspondence:
- 1. Mant A, Kehoe L, Cockayne NL, et al. A Quality Use of Medicines program for continuity of care in therapeutics from hospital to community. Med J Aust 2002; 177: 32-34. <eMJA full text>
- 2. New PW. A Quality Use of Medicines program for continuity of care in therapeutics from hospital to community [letter]. Med J Aust 2002; 177: 575. <eMJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.